Nature Communications

Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

2025-09-05

Full text

DOI https://doi.org/10.1038/s41467-025-63690-x